25 XP   0   0   10

Gamida Cell Ltd
Buy, Hold or Sell?

Let's analyse Gamida Cell Ltd together

PenkeI guess you are interested in Gamida Cell Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Gamida Cell Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Gamida Cell Ltd

I send you an email if I find something interesting about Gamida Cell Ltd.

Quick analysis of Gamida Cell Ltd (30 sec.)










What can you expect buying and holding a share of Gamida Cell Ltd? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
3.6%

What is your share worth?

Current worth
$-0.02
Expected worth in 1 year
$0.02
How sure are you?
32.1%

+ What do you gain per year?

Total Gains per Share
$0.04
Return On Investment
122.5%

For what price can you sell your share?

Current Price per Share
$0.03
Expected price per share
$0 - $0.31
How sure are you?
50%

1. Valuation of Gamida Cell Ltd (5 min.)




Live pricePrice per Share (EOD)

$0.03

Intrinsic Value Per Share

$-4.35 - $-4.97

Total Value Per Share

$-4.37 - $-4.99

2. Growth of Gamida Cell Ltd (5 min.)




Is Gamida Cell Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?-$2.9m$9.5m-$20.5m-187.9%

How much money is Gamida Cell Ltd making?

Current yearPrevious yearGrowGrow %
Making money-$16m-$29.9m$13.8m85.8%
Net Profit Margin-255.4%0.0%--

How much money comes from the company's main activities?

3. Financial Health of Gamida Cell Ltd (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#910 / 1010

Most Revenue
#555 / 1010

Most Profit
#645 / 1010

Most Efficient
#659 / 1010

What can you expect buying and holding a share of Gamida Cell Ltd? (5 min.)

Welcome investor! Gamida Cell Ltd's management wants to use your money to grow the business. In return you get a share of Gamida Cell Ltd.

What can you expect buying and holding a share of Gamida Cell Ltd?

First you should know what it really means to hold a share of Gamida Cell Ltd. And how you can make/lose money.

Speculation

The Price per Share of Gamida Cell Ltd is $0.0327. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Gamida Cell Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Gamida Cell Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $-0.02. Based on the TTM, the Book Value Change Per Share is $0.01 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.10 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Gamida Cell Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.06-187.2%-0.12-358.9%-0.15-446.9%-0.13-387.9%-0.12-360.4%
Usd Book Value Change Per Share-0.02-71.2%0.0130.6%-0.10-299.5%-0.01-31.6%0.00-2.2%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.1%0.000.1%
Usd Total Gains Per Share-0.02-71.2%0.0130.6%-0.10-299.5%-0.01-31.5%0.00-2.2%
Usd Price Per Share0.41-1.05-2.20-3.95-3.18-
Price to Earnings Ratio-1.69--6.87--3.74--6.70--5.31-
Price-to-Total Gains Ratio-17.72--12.96--3.44--23.77--20.51-
Price to Book Ratio-20.21-80.12-11.54-31.54-24.44-
Price-to-Total Gains Ratio-17.72--12.96--3.44--23.77--20.51-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.0327
Number of shares30581
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.01-0.01
Usd Total Gains Per Share0.01-0.01
Gains per Quarter (30581 shares)306.35-314.70
Gains per Year (30581 shares)1,225.42-1,258.80
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10122512154-1263-1269
20245124409-2526-2528
303676366513-3790-3787
404902489018-5053-5046
506127611522-6316-6305
607353734027-7579-7564
708578856531-8843-8823
809803979035-10106-10082
90110291101540-11369-11341
100122541224044-12632-12600

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%1.019.00.05.0%1.027.00.03.6%1.027.00.03.6%
Book Value Change Per Share1.03.00.025.0%2.010.00.016.7%6.014.00.030.0%9.018.01.032.1%9.018.01.032.1%
Dividend per Share0.00.04.00.0%0.00.012.00.0%1.00.019.05.0%1.00.027.03.6%1.00.027.03.6%
Total Gains per Share1.03.00.025.0%2.010.00.016.7%6.014.00.030.0%9.018.01.032.1%9.018.01.032.1%

Fundamentals of Gamida Cell Ltd

About Gamida Cell Ltd

Gamida Cell Ltd., a clinical-stage biopharmaceutical company, develops cell therapies to cure blood cancers and serious blood diseases. The company's lead product candidate is omidubicel, a cell therapy that has completed Phase III clinical trial in patients with hematologic malignancies, as well as in Phase II clinical trials in patients with severe aplastic anemia. It is also developing GDA-201, an investigational NK cell-based cancer immunotherapy, which is in Phase I/II studies for the treatment of relapsed or refractory non-Hodgkin lymphoma and multiple myeloma. The company was incorporated in 1998 and is headquartered in Jerusalem, Israel.

Fundamental data was last updated by Penke on 2024-04-11 10:01:02.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Gamida Cell Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Gamida Cell Ltd earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Gamida Cell Ltd to the Biotechnology industry mean.
  • A Net Profit Margin of -795.8% means that $-7.96 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Gamida Cell Ltd:

  • The MRQ is -795.8%. The company is making a huge loss. -2
  • The TTM is -255.4%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-795.8%TTM-255.4%-540.4%
TTM-255.4%YOY--255.4%
TTM-255.4%5Y-51.1%-204.3%
5Y-51.1%10Y-36.5%-14.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-795.8%-207.2%-588.6%
TTM-255.4%-216.8%-38.6%
YOY--282.3%+282.3%
5Y-51.1%-436.8%+385.7%
10Y-36.5%-597.3%+560.8%
1.1.2. Return on Assets

Shows how efficient Gamida Cell Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Gamida Cell Ltd to the Biotechnology industry mean.
  • -8.7% Return on Assets means that Gamida Cell Ltd generated $-0.09 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Gamida Cell Ltd:

  • The MRQ is -8.7%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -14.8%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-8.7%TTM-14.8%+6.2%
TTM-14.8%YOY-25.5%+10.6%
TTM-14.8%5Y-16.5%+1.7%
5Y-16.5%10Y-22.3%+5.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-8.7%-13.3%+4.6%
TTM-14.8%-12.8%-2.0%
YOY-25.5%-11.6%-13.9%
5Y-16.5%-13.8%-2.7%
10Y-22.3%-15.6%-6.7%
1.1.3. Return on Equity

Shows how efficient Gamida Cell Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Gamida Cell Ltd to the Biotechnology industry mean.
  • 0.0% Return on Equity means Gamida Cell Ltd generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Gamida Cell Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-99.4%+99.4%
TTM-99.4%YOY-171.9%+72.5%
TTM-99.4%5Y-76.2%-23.2%
5Y-76.2%10Y-83.4%+7.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--16.9%+16.9%
TTM-99.4%-16.1%-83.3%
YOY-171.9%-14.9%-157.0%
5Y-76.2%-19.3%-56.9%
10Y-83.4%-20.1%-63.3%

1.2. Operating Efficiency of Gamida Cell Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Gamida Cell Ltd is operating .

  • Measures how much profit Gamida Cell Ltd makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Gamida Cell Ltd to the Biotechnology industry mean.
  • An Operating Margin of -1,460.2% means the company generated $-14.60  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Gamida Cell Ltd:

  • The MRQ is -1,460.2%. The company is operating very inefficient. -2
  • The TTM is -1,035.1%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-1,460.2%TTM-1,035.1%-425.1%
TTM-1,035.1%YOY--1,035.1%
TTM-1,035.1%5Y-207.0%-828.1%
5Y-207.0%10Y-147.9%-59.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-1,460.2%-298.0%-1,162.2%
TTM-1,035.1%-238.5%-796.6%
YOY--288.4%+288.4%
5Y-207.0%-486.2%+279.2%
10Y-147.9%-628.4%+480.5%
1.2.2. Operating Ratio

Measures how efficient Gamida Cell Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 15.60 means that the operating costs are $15.60 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Gamida Cell Ltd:

  • The MRQ is 15.602. The company is inefficient in keeping operating costs low. -1
  • The TTM is 10.851. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ15.602TTM10.851+4.751
TTM10.851YOY-+10.851
TTM10.8515Y2.170+8.681
5Y2.17010Y1.550+0.620
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ15.6023.235+12.367
TTM10.8513.310+7.541
YOY-3.838-3.838
5Y2.1705.679-3.509
10Y1.5507.823-6.273

1.3. Liquidity of Gamida Cell Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Gamida Cell Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 2.16 means the company has $2.16 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Gamida Cell Ltd:

  • The MRQ is 2.164. The company is able to pay all its short-term debts. +1
  • The TTM is 2.621. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.164TTM2.621-0.456
TTM2.621YOY2.890-0.269
TTM2.6215Y4.637-2.017
5Y4.63710Y5.594-0.957
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.1643.863-1.699
TTM2.6214.169-1.548
YOY2.8905.337-2.447
5Y4.6376.122-1.485
10Y5.5946.434-0.840
1.3.2. Quick Ratio

Measures if Gamida Cell Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Gamida Cell Ltd to the Biotechnology industry mean.
  • A Quick Ratio of 2.15 means the company can pay off $2.15 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Gamida Cell Ltd:

  • The MRQ is 2.154. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 2.457. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.154TTM2.457-0.303
TTM2.457YOY3.392-0.935
TTM2.4575Y5.183-2.726
5Y5.18310Y6.185-1.002
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.1543.504-1.350
TTM2.4573.991-1.534
YOY3.3925.371-1.979
5Y5.1836.088-0.905
10Y6.1856.395-0.210

1.4. Solvency of Gamida Cell Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Gamida Cell Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Gamida Cell Ltd to Biotechnology industry mean.
  • A Debt to Asset Ratio of 1.03 means that Gamida Cell Ltd assets are financed with 102.9% credit (debt) and the remaining percentage (100% - 102.9%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Gamida Cell Ltd:

  • The MRQ is 1.029. The company is just not able to pay all its debts by selling its assets. -1
  • The TTM is 1.100. The company is just not able to pay all its debts by selling its assets. -1
Trends
Current periodCompared to+/- 
MRQ1.029TTM1.100-0.071
TTM1.100YOY0.918+0.182
TTM1.1005Y0.734+0.366
5Y0.73410Y0.711+0.023
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0290.339+0.690
TTM1.1000.337+0.763
YOY0.9180.271+0.647
5Y0.7340.368+0.366
10Y0.7110.388+0.323
1.4.2. Debt to Equity Ratio

Measures if Gamida Cell Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Gamida Cell Ltd to the Biotechnology industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Gamida Cell Ltd:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM76.810-76.810
TTM76.810YOY6.044+70.767
TTM76.8105Y17.479+59.331
5Y17.47910Y13.022+4.457
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.392-0.392
TTM76.8100.403+76.407
YOY6.0440.335+5.709
5Y17.4790.427+17.052
10Y13.0220.461+12.561

2. Market Valuation of Gamida Cell Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Gamida Cell Ltd generates.

  • Above 15 is considered overpriced but always compare Gamida Cell Ltd to the Biotechnology industry mean.
  • A PE ratio of -1.69 means the investor is paying $-1.69 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Gamida Cell Ltd:

  • The EOD is -0.134. Based on the earnings, the company is expensive. -2
  • The MRQ is -1.686. Based on the earnings, the company is expensive. -2
  • The TTM is -6.868. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.134MRQ-1.686+1.552
MRQ-1.686TTM-6.868+5.182
TTM-6.868YOY-3.743-3.125
TTM-6.8685Y-6.703-0.166
5Y-6.70310Y-5.308-1.395
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.134-2.300+2.166
MRQ-1.686-2.656+0.970
TTM-6.868-2.718-4.150
YOY-3.743-4.145+0.402
5Y-6.703-6.258-0.445
10Y-5.308-6.315+1.007
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Gamida Cell Ltd:

  • The EOD is -0.075. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.949. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -1.715. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.075MRQ-0.949+0.874
MRQ-0.949TTM-1.715+0.766
TTM-1.715YOY-3.669+1.954
TTM-1.7155Y-8.947+7.232
5Y-8.94710Y-7.727-1.219
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.075-2.974+2.899
MRQ-0.949-3.306+2.357
TTM-1.715-3.508+1.793
YOY-3.669-5.613+1.944
5Y-8.947-8.378-0.569
10Y-7.727-8.873+1.146
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Gamida Cell Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of -20.21 means the investor is paying $-20.21 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Gamida Cell Ltd:

  • The EOD is -1.602. Based on the equity, the company is expensive. -2
  • The MRQ is -20.214. Based on the equity, the company is expensive. -2
  • The TTM is 80.119. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.602MRQ-20.214+18.613
MRQ-20.214TTM80.119-100.334
TTM80.119YOY11.541+68.578
TTM80.1195Y31.543+48.576
5Y31.54310Y24.438+7.105
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.6021.914-3.516
MRQ-20.2142.116-22.330
TTM80.1192.097+78.022
YOY11.5412.881+8.660
5Y31.5433.550+27.993
10Y24.4383.936+20.502
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Gamida Cell Ltd.

3.1. Institutions holding Gamida Cell Ltd

Institutions are holding 26.489% of the shares of Gamida Cell Ltd.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31JANE STREET GROUP, LLC0.0146019333193330
2023-12-31PNC Financial Services Group Inc0.00410550000
2023-12-31JPMorgan Chase & Co0.00140183818380
2023-12-31Marshall Wace Asset Management Ltd000-18761-100
2023-09-30Stock Yards Bank & Trust Co000-50000-100
2023-09-30Meritage Portfolio Management000-13000-100
2023-09-30Denali Advisors LLC000-59300-100
2023-12-31Victory Capital Management Inc.000-10950-100
2023-12-31ARK Investment Management LLC000-1419616-100
2023-12-31Atwood & Palmer Inc000-1000-100
2023-09-30Lazard Asset Management LLC000-16009-100
Total 0.0201026671-1567465-5,877.0%

3.2. Funds holding Gamida Cell Ltd

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-01-31Fidelity VIP Growth Initial1.66790.0093221226800
2024-01-31Fidelity Capital Appreciation1.63530.0138216905300
2024-01-31Fidelity Advisor Equity Growth I1.42680.00851892438-2678-0.1413
2024-01-31Fidelity Growth Discovery0.7510.008399612100
2024-02-29Pacific Select Large-Cap Growth I0.25220.007533450000
2024-02-29iShares Micro-Cap ETF0.20310.010626936900
2024-01-31Fidelity Advisor Series Equity Gr0.20070.008626622900
2024-01-31Vifag 2002 SICAV0.07540.065410000000
2024-01-31Fidelity Nasdaq Composite Index0.06320.00028384300
2024-01-31Fidelity VIP Dynamic Cap App Initial0.05690.01237551400
2023-12-31Dolphin 90/10 IL0.0490.00786500000
2023-12-31Guardian Large Cap Fundamental Gr VIP0.04510.015980000
2023-12-31AVIP Fidelity Instl AM® Eq Gr Prtfl0.02510.011833274332740
2024-01-311290 VT Micro Cap K0.01240.00451639500
2023-12-31Dolphin Flexible0.01060.08861400000
2024-01-31Fidelity Equity Growth K60.00590.009785775602545.4545
2023-12-31Dolphin Stocks IL0.0030.0366400000
2023-12-31Dolphin75/25 IL0.0020.0068270000
2024-02-29LUX IM Global Medtech HX0.00150.0004204600
2024-02-29ARK Israel Innovative Technology ETF0.00110.0005150500
Total 6.48820.32058605912+38156+0.4%

3.3. Insider Transactions

Insiders are holding 11.578% of the shares of Gamida Cell Ltd.

DateOwnerTypeAmountPricePost Transaction AmountLink
2022-09-30Abigail L JenkinsBUY161291.55
2022-09-30Stephen T WillsBUY96771.55

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Gamida Cell Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.0230.010-333%-0.098+320%-0.010-56%-0.001-97%
Book Value Per Share---0.020-0.082+301%0.072-128%0.230-109%0.194-111%
Current Ratio--2.1642.621-17%2.890-25%4.637-53%5.594-61%
Debt To Asset Ratio--1.0291.100-6%0.918+12%0.734+40%0.711+45%
Debt To Equity Ratio---76.810-100%6.044-100%17.479-100%13.022-100%
Dividend Per Share----0%-0%0.000-100%0.000-100%
Eps---0.061-0.117+92%-0.146+139%-0.127+107%-0.118+93%
Free Cash Flow Per Share---0.109-0.147+35%-0.145+33%-0.133+22%-0.110+1%
Free Cash Flow To Equity Per Share---0.093-0.032-66%-0.060-36%-0.003-97%0.008-1276%
Gross Profit Margin--1.4621.115+31%1.053+39%1.041+40%1.029+42%
Intrinsic Value_10Y_max---4.966--------
Intrinsic Value_10Y_min---4.352--------
Intrinsic Value_1Y_max---0.614--------
Intrinsic Value_1Y_min---0.603--------
Intrinsic Value_3Y_max---1.756--------
Intrinsic Value_3Y_min---1.678--------
Intrinsic Value_5Y_max---2.791--------
Intrinsic Value_5Y_min---2.598--------
Market Cap4337295.300-1274%59611920.768139915237.692-57%291805800.000-80%524716102.538-89%421884061.099-86%
Net Profit Margin---7.958-2.554-68%--100%-0.511-94%-0.365-95%
Operating Margin---14.602-10.351-29%--100%-2.070-86%-1.479-90%
Operating Ratio--15.60210.851+44%-+100%2.170+619%1.550+906%
Pb Ratio-1.602+92%-20.21480.119-125%11.541-275%31.543-164%24.438-183%
Pe Ratio-0.134+92%-1.686-6.868+307%-3.743+122%-6.703+298%-5.308+215%
Price Per Share0.033-1162%0.4131.046-61%2.200-81%3.954-90%3.179-87%
Price To Free Cash Flow Ratio-0.075+92%-0.949-1.715+81%-3.669+287%-8.947+843%-7.727+714%
Price To Total Gains Ratio-1.404+92%-17.715-12.963-27%-3.436-81%-23.771+34%-20.513+16%
Quick Ratio--2.1542.457-12%3.392-37%5.183-58%6.185-65%
Return On Assets---0.087-0.148+71%-0.255+194%-0.165+91%-0.223+158%
Return On Equity----0.9940%-1.7190%-0.7620%-0.8340%
Total Gains Per Share---0.0230.010-333%-0.098+320%-0.010-56%-0.001-97%
Usd Book Value---2949000.000-10911750.000+270%9593000.000-131%30466950.000-110%25775678.571-111%
Usd Book Value Change Per Share---0.0230.010-333%-0.098+320%-0.010-56%-0.001-97%
Usd Book Value Per Share---0.020-0.082+301%0.072-128%0.230-109%0.194-111%
Usd Dividend Per Share----0%-0%0.000-100%0.000-100%
Usd Eps---0.061-0.117+92%-0.146+139%-0.127+107%-0.118+93%
Usd Free Cash Flow---15704668.000-19848667.000+26%-19194250.000+22%-17720033.400+13%-14648059.571-7%
Usd Free Cash Flow Per Share---0.109-0.147+35%-0.145+33%-0.133+22%-0.110+1%
Usd Free Cash Flow To Equity Per Share---0.093-0.032-66%-0.060-36%-0.003-97%0.008-1276%
Usd Market Cap4337295.300-1274%59611920.768139915237.692-57%291805800.000-80%524716102.538-89%421884061.099-86%
Usd Price Per Share0.033-1162%0.4131.046-61%2.200-81%3.954-90%3.179-87%
Usd Profit---8841000.000-16094000.000+82%-29906250.000+238%-19042450.000+115%-16781714.286+90%
Usd Revenue--1111000.000446000.000+149%-+100%89200.000+1146%63714.286+1644%
Usd Total Gains Per Share---0.0230.010-333%-0.098+320%-0.010-56%-0.001-97%
 EOD+2 -6MRQTTM+16 -17YOY+16 -175Y+13 -2210Y+12 -23

4.2. Fundamental Score

Let's check the fundamental score of Gamida Cell Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.134
Price to Book Ratio (EOD)Between0-1-1.602
Net Profit Margin (MRQ)Greater than0-7.958
Operating Margin (MRQ)Greater than0-14.602
Quick Ratio (MRQ)Greater than12.154
Current Ratio (MRQ)Greater than12.164
Debt to Asset Ratio (MRQ)Less than11.029
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-0.087
Total3/10 (30.0%)

4.3. Technical Score

Let's check the technical score of Gamida Cell Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5022.451
Ma 20Greater thanMa 500.244
Ma 50Greater thanMa 1000.322
Ma 100Greater thanMa 2000.324
OpenGreater thanClose0.040
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets102,186
Total Liabilities105,135
Total Stockholder Equity-2,949
 As reported
Total Liabilities 105,135
Total Stockholder Equity+ -2,949
Total Assets = 102,186

Assets

Total Assets102,186
Total Current Assets54,546
Long-term Assets47,640
Total Current Assets
Cash And Cash Equivalents 49,610
Short-term Investments 3,056
Net Receivables 1,610
Other Current Assets 1,420
Total Current Assets  (as reported)54,546
Total Current Assets  (calculated)55,696
+/- 1,150
Long-term Assets
Property Plant Equipment 44,441
Long-term Assets Other 2,822
Long-term Assets  (as reported)47,640
Long-term Assets  (calculated)47,263
+/- 377

Liabilities & Shareholders' Equity

Total Current Liabilities25,201
Long-term Liabilities79,934
Total Stockholder Equity-2,949
Total Current Liabilities
Short-term Debt 7,775
Short Long Term Debt 6,505
Accounts payable 1,880
Other Current Liabilities 15,546
Total Current Liabilities  (as reported)25,201
Total Current Liabilities  (calculated)31,706
+/- 6,505
Long-term Liabilities
Long term Debt 73,041
Capital Lease Obligations 3,397
Long-term Liabilities Other 1,482
Long-term Liabilities  (as reported)79,934
Long-term Liabilities  (calculated)77,920
+/- 2,014
Total Stockholder Equity
Common Stock391
Retained Earnings -479,828
Other Stockholders Equity 476,488
Total Stockholder Equity (as reported)-2,949
Total Stockholder Equity (calculated)-2,949
+/-0
Other
Capital Stock391
Cash and Short Term Investments 49,610
Common Stock Shares Outstanding 144,444
Liabilities and Stockholders Equity 102,186
Net Debt 33,333
Net Invested Capital 76,597
Net Working Capital 29,345
Property Plant and Equipment Gross 49,316
Short Long Term Debt Total 82,943



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302016-12-31
> Total Assets 
19,179
12,550
47,970
44,922
0
32,848
28,512
65,164
61,047
53,531
79,679
68,775
56,929
113,215
98,708
155,483
206,004
186,720
165,161
148,786
124,538
108,021
114,312
124,773
105,132
112,508
117,748
102,186
102,186117,748112,508105,132124,773114,312108,021124,538148,786165,161186,720206,004155,48398,708113,21556,92968,77579,67953,53161,04765,16428,51232,848044,92247,97012,55019,179
   > Total Current Assets 
18,436
11,510
47,090
43,622
0
30,161
24,697
62,191
50,940
42,582
69,251
56,703
41,929
90,879
75,045
129,985
178,150
153,922
123,621
98,614
72,712
57,356
62,703
66,546
48,167
58,865
68,509
54,546
54,54668,50958,86548,16766,54662,70357,35672,71298,614123,621153,922178,150129,98575,04590,87941,92956,70369,25142,58250,94062,19124,69730,161043,62247,09011,51018,436
       Cash And Cash Equivalents 
18,059
9,800
44,650
21,325
0
19,004
14,109
40,272
43,749
37,078
39,573
41,838
40,292
88,638
73,311
127,170
174,798
100,490
80,613
55,892
42,057
37,890
55,071
64,657
46,763
54,075
60,431
49,610
49,61060,43154,07546,76364,65755,07137,89042,05755,89280,613100,490174,798127,17073,31188,63840,29241,83839,57337,07843,74940,27214,10919,004021,32544,6509,80018,059
       Short-term Investments 
0
0
19,758
14,758
0
9,632
9,570
20,417
6,507
4,618
28,544
13,559
0
0
0
0
0
49,702
40,223
40,034
27,661
17,172
6,224
0
0
0
0
3,056
3,05600006,22417,17227,66140,03440,22349,7020000013,55928,5444,6186,50720,4179,5709,632014,75819,75800
       Net Receivables 
112
0
1,578
1,578
0
0
0
0
0
0
0
7
0
0
0
103
0
0
0
0
0
0
0
0
0
138
676
1,610
1,610676138000000000103000700000001,5781,5780112
       Other Current Assets 
265
1,710
2,440
2,539
0
1,525
868
1,502
684
886
1,134
1,306
1,637
2,241
1,734
2,815
3,352
3,730
2,785
2,688
2,994
2,294
1,408
1,889
1,404
2,262
2,355
1,420
1,4202,3552,2621,4041,8891,4082,2942,9942,6882,7853,7303,3522,8151,7342,2411,6371,3061,1348866841,5028681,52502,5392,4401,710265
   > Long-term Assets 
0
1,040
880
1,300
0
2,687
3,815
2,973
10,107
10,949
10,428
12,072
15,000
22,336
23,663
25,498
27,854
32,798
41,540
50,172
51,826
50,665
51,609
58,227
56,965
53,643
49,239
47,640
47,64049,23953,64356,96558,22751,60950,66551,82650,17241,54032,79827,85425,49823,66322,33615,00012,07210,42810,94910,1072,9733,8152,68701,3008801,0400
       Property Plant Equipment 
700
840
830
940
0
1,546
1,743
2,311
9,450
9,594
9,777
11,431
14,363
21,694
22,861
24,712
27,082
31,011
34,941
42,416
44,255
44,074
45,399
51,343
50,370
47,975
46,373
44,441
44,44146,37347,97550,37051,34345,39944,07444,25542,41634,94131,01127,08224,71222,86121,69414,36311,4319,7779,5949,4502,3111,7431,5460940830840700
       Long-term Assets Other 
0
200
50
360
0
1,141
2,072
662
657
1,355
651
641
637
642
802
786
772
1,787
6,599
-32,278
7,571
6,591
2,654
3,216
2,915
2,518
2,489
2,822
2,8222,4892,5182,9153,2162,6546,5917,571-32,2786,5991,7877727868026426376416511,3556576622,0721,1410360502000
> Total Liabilities 
8,216
9,210
19,600
21,966
0
28,885
33,367
40,477
47,902
32,979
30,756
33,792
31,647
38,665
38,140
56,746
122,107
122,636
119,205
104,849
99,554
100,171
100,751
132,796
120,499
138,221
117,366
105,135
105,135117,366138,221120,499132,796100,751100,17199,554104,849119,205122,636122,10756,74638,14038,66531,64733,79230,75632,97947,90240,47733,36728,885021,96619,6009,2108,216
   > Total Current Liabilities 
1,898
2,350
2,210
4,576
0
5,215
7,299
6,705
7,816
9,518
9,106
11,395
10,104
13,579
13,926
21,554
19,867
22,625
23,660
25,433
20,478
22,297
22,713
24,875
22,273
20,738
20,654
25,201
25,20120,65420,73822,27324,87522,71322,29720,47825,43323,66022,62519,86721,55413,92613,57910,10411,3959,1069,5187,8166,7057,2995,21504,5762,2102,3501,898
       Short-term Debt 
0
0
0
0
0
0
0
0
2,156
1,945
1,926
1,870
1,535
2,145
2,345
2,532
2,076
1,937
1,622
2,699
2,596
2,517
1,880
2,648
2,082
2,176
1,497
7,775
7,7751,4972,1762,0822,6481,8802,5172,5962,6991,6221,9372,0762,5322,3452,1451,5351,8701,9261,9452,15600000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
2,156
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,505
6,5050000000000000000002,15600000000
       Accounts payable 
926
1,030
1,490
2,390
0
1,158
3,060
1,985
1,341
2,121
2,105
1,164
3,098
2,738
2,704
6,329
7,204
5,435
7,833
8,272
4,346
2,738
1,916
6,384
4,398
2,440
1,664
1,880
1,8801,6642,4404,3986,3841,9162,7384,3468,2727,8335,4357,2046,3292,7042,7383,0981,1642,1052,1211,3411,9853,0601,15802,3901,4901,030926
       Other Current Liabilities 
972
1,320
720
2,186
0
4,057
4,239
4,720
4,319
5,452
5,075
8,361
5,471
8,696
8,877
12,693
10,587
15,253
14,205
-8,272
13,536
17,042
18,917
15,843
15,793
16,122
17,493
15,546
15,54617,49316,12215,79315,84318,91717,04213,536-8,27214,20515,25310,58712,6938,8778,6965,4718,3615,0755,4524,3194,7204,2394,05702,1867201,320972
   > Long-term Liabilities 
0
6,860
17,390
17,390
0
23,670
26,068
33,772
40,086
23,461
21,650
22,397
21,543
25,086
24,214
35,192
102,240
100,011
95,545
79,416
79,076
77,874
78,038
107,921
98,226
117,483
96,712
79,934
79,93496,712117,48398,226107,92178,03877,87479,07679,41695,545100,011102,24035,19224,21425,08621,54322,39721,65023,46140,08633,77226,06823,670017,39017,3906,8600
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
4,671
4,627
4,342
4,101
4,920
5,946
5,460
5,378
0
0
0
5,603
5,142
4,233
4,174
4,867
2,976
2,461
2,302
-4,378
-4,3782,3022,4612,9764,8674,1744,2335,1425,6030005,3785,4605,9464,9204,1014,3424,6274,67100000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
35,139
18,560
17,028
17,523
15,850
18,367
17,981
29,046
32,826
30,218
25,479
0
0
0
0
4,690
2,742
1,873
0
1,482
1,48201,8732,7424,690000025,47930,21832,82629,04617,98118,36715,85017,52317,02818,56035,13900000000
       Deferred Long Term Liability 
0
0
0
0
0
0
1,718
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000001,718000000
> Total Stockholder Equity
10,963
3,340
28,370
22,956
22,918
3,963
-4,855
24,687
13,145
20,552
48,923
34,983
25,282
74,550
60,568
98,737
83,897
64,084
45,956
43,937
24,984
7,850
13,561
-8,023
-15,367
-25,713
382
-2,949
-2,949382-25,713-15,367-8,02313,5617,85024,98443,93745,95664,08483,89798,73760,56874,55025,28234,98348,92320,55213,14524,687-4,8553,96322,91822,95628,3703,34010,963
   Common Stock
2
0
2
2
0
40
2
67
68
69
92
92
92
137
138
166
167
167
167
169
169
169
210
211
222
305
357
391
39135730522221121016916916916716716716613813792929269686724002202
   Retained Earnings Total Equity0000000000000000000000000000
   Accumulated Other Comprehensive Income 000000000-483-466-441-4410-541-214,166-537-158-161-170-120-126-2480-113000
   Capital Surplus 
0
0
0
0
0
0
0
193,953
197,967
199,402
237,843
238,992
239,897
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000239,897238,992237,843199,402197,967193,9530000000
   Treasury Stock0000000000000000000000000000
   Other Stockholders Equity 
-44
109,980
138,950
139,311
0
140,934
141,816
193,953
197,967
199,402
237,843
238,992
239,356
304,175
60,568
375,280
378,478
379,981
381,504
381,225
382,495
383,915
407,387
408,598
422,203
443,450
471,012
476,488
476,488471,012443,450422,203408,598407,387383,915382,495381,225381,504379,981378,478375,28060,568304,175239,356238,992237,843199,402197,967193,953141,816140,9340139,311138,950109,980-44



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue1,784
Cost of Revenue-3,478
Gross Profit-1,694-1,694
 
Operating Income (+$)
Gross Profit-1,694
Operating Expense-70,949
Operating Income-72,643-72,643
 
Operating Expense (+$)
Research Development22,284
Selling General Administrative44,584
Selling And Marketing Expenses4,081
Operating Expense70,94970,949
 
Net Interest Income (+$)
Interest Income2,727
Interest Expense-7,587
Other Finance Cost-4,892
Net Interest Income32
 
Pretax Income (+$)
Operating Income-72,643
Net Interest Income32
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-62,996-82,290
EBIT - interestExpense = -80,230
-62,996
-55,409
Interest Expense7,587
Earnings Before Interest and Taxes (EBIT)-72,643-55,409
Earnings Before Interest and Taxes (EBITDA)-70,619
 
After tax Income (+$)
Income Before Tax-62,996
Tax Provision-0
Net Income From Continuing Ops-76,951-62,996
Net Income-62,996
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses74,427
Total Other Income/Expenses Net9,647-32
 

Technical Analysis of Gamida Cell Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Gamida Cell Ltd. The general trend of Gamida Cell Ltd is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Gamida Cell Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Gamida Cell Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.2184 < 0.24 < 0.31.

The bearish price targets are: .

Tweet this
Gamida Cell Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Gamida Cell Ltd. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Gamida Cell Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Gamida Cell Ltd. The current macd is -0.08734366.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Gamida Cell Ltd price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Gamida Cell Ltd. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Gamida Cell Ltd price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Gamida Cell Ltd Daily Moving Average Convergence/Divergence (MACD) ChartGamida Cell Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Gamida Cell Ltd. The current adx is 29.48.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Gamida Cell Ltd shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
Gamida Cell Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Gamida Cell Ltd. The current sar is 0.28038582.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Gamida Cell Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Gamida Cell Ltd. The current rsi is 22.45. The current phase is Oversold in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 0/(-13 +13).

  • Oversold in bear market: Short-term excessive selling, potential for relief rally. Be cautious, consider taking short-term long positions. +1
  • Trending down: The RSI is trending down. -1
Gamida Cell Ltd Daily Relative Strength Index (RSI) ChartGamida Cell Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Gamida Cell Ltd. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Gamida Cell Ltd price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Gamida Cell Ltd Daily Stochastic Oscillator ChartGamida Cell Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Gamida Cell Ltd. The current cci is -98.95845605.

Gamida Cell Ltd Daily Commodity Channel Index (CCI) ChartGamida Cell Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Gamida Cell Ltd. The current cmo is -65.64249307.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Gamida Cell Ltd Daily Chande Momentum Oscillator (CMO) ChartGamida Cell Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Gamida Cell Ltd. The current willr is -99.38414165.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Gamida Cell Ltd Daily Williams %R ChartGamida Cell Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Gamida Cell Ltd.

Gamida Cell Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Gamida Cell Ltd. The current atr is 0.04108647.

Gamida Cell Ltd Daily Average True Range (ATR) ChartGamida Cell Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Gamida Cell Ltd. The current obv is -129,780,560.

Gamida Cell Ltd Daily On-Balance Volume (OBV) ChartGamida Cell Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Gamida Cell Ltd. The current mfi is 36.34.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Gamida Cell Ltd Daily Money Flow Index (MFI) ChartGamida Cell Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Gamida Cell Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-13STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-14BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-11-15STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-16STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-17STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-21STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-11-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-30STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-05SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-07RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2023-12-11STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-12CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-14STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-15RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2023-12-18STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-27CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-04CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-08WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-19STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-24WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-25CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-29STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-02SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-05CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-21STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-23DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-28DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-06CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-07WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-12STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-18DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-21STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-25SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-03STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Gamida Cell Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Gamida Cell Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5022.451
Ma 20Greater thanMa 500.244
Ma 50Greater thanMa 1000.322
Ma 100Greater thanMa 2000.324
OpenGreater thanClose0.040
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Gamida Cell Ltd with someone you think should read this too:
  • Are you bullish or bearish on Gamida Cell Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Gamida Cell Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Gamida Cell Ltd

I send you an email if I find something interesting about Gamida Cell Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Gamida Cell Ltd.

Receive notifications about Gamida Cell Ltd in your mailbox!